Using a genetic, observational study as a strategy to estimate the potential cost-effectiveness of pharmacological CCR5 blockade in dialysis patients

Author(s):
Muntinghe, F.L.H.; Vegter, S.; Verduijn, M.; Boeschoten, E.W.; Dekker, F.W. (0000-0002-2433-2494); Navis, G.; Postma, M.
Published
2011
Publication type
Article / Letter to editor
CC-chemokine receptor 5chemokine-receptor cost-effectivenessdialysisMendelianpolymorphism
Date issued
2011-07-31
Language
English
Is part of
Pharmacogenetics and Genomics (2011), Vol. 21, no. 7, p. 417-425
hdl
1887/109943
doi
10.1097/FPC.0b013e3283472990